Grants per year
- 1 - 25 out of 30 results
Search results
-
Finished
Prot #EVM-22656: Embedded Clinical Trial Interview Study in Cutaneous T-cell Lymphoma (CTCL) to Capture Meaningful Treatment Benefit(s) from a Patient’s Perspective
Guitart, J. (PD/PI)
Evidera, Inc., Galderma R&D LLC
2/21/20 → 2/21/21
Project: Research project
-
Characterization of the skin microbiome in cutaneous T cell lymphoma
Guitart, J. (PD/PI) & Zhou, A. (Other)
7/1/18 → 6/30/19
Project: Research project
-
Prot #RD.03.SPR.104003: A Randomized, Double-Blind, Multi-Centre, Placebo-Controlled, Parallel-Arm Phase 2 Trial to Assess Safety, Efficacy and Pharmacokinetics of CD11301 0.03% and 0.06% Gel in the Treatment of Cutaneous T-Cell Lymphoma (CTCL), Stages IA
Guitart, J. (PD/PI)
Premier Research International, LLC, Galderma Research & Development, SNC
3/20/18 → 3/20/21
Project: Research project
-
A double blind, randomized, vehicle controlled, crossover study with an open-label long-term extension, to evaluate the safety and efficacy of topical naloxone hydrochloride lotion, 0.5%, for the relief of pruritus in patients with the mycosis fungoides (
Guitart, J. (PD/PI)
Elorac, Inc., Food and Drug Administration
2/22/17 → 2/21/23
Project: Research project
-
Transforming the diagnosis and care of patients with CTCL using TCR sequencing
Guitart, J. (PD/PI)
Brigham and Women’s Hospital, National Cancer Institute
4/23/16 → 3/31/21
Project: Research project
-
Prot #MRG106-11-101: A Phase 1 Dose-Ranging Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MRG-106 following Local Intratumoral and Subcutaneous Injection in Patients with Cutaneous T-cell Lymphoma (CTCL), Mycosis Fungoides (MF) Su
Guitart, J. (PD/PI)
Novella Clinical, LLC, miRagen Therapeutics, Inc.
12/8/15 → 6/30/19
Project: Research project
-
Prot #HPN-CTCL-01: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell Lymphoma
Guitart, J. (PD/PI)
7/29/15 → 7/29/21
Project: Research project
-
Development of Consensus Criteria and Guidelines for the Diagnosis and Treatment of Aggressive Cytotoxic Cutaneous Lymphoma
Guitart, J. (PD/PI)
3/27/15 → 6/30/17
Project: Research project
-
Prot #AC-079A501: A PROspective, Observational, U.S.-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed with Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated with Valchlor
Guitart, J. (PD/PI)
DrugDev Inc., Actelion Pharmaceuticals US, Inc.
3/6/15 → 3/6/19
Project: Research project
-
Prot #SHP-141-003: A Randomized Phase 2 Study to Evaluate Three Treatment Regimens of SHAPE, a Histone Deacetylase Inhibitor, in Patients with Stage IA, IB or IIA Cutaneous T-Cell Lymphoma
Guitart, J. (PD/PI)
INC Research, LLC, TetraLogic Pharmaceuticals Corporation
11/17/14 → 11/17/17
Project: Research project
-
Core C
Guitart, J. (PD/PI) & Guitart, J. (Subproject PI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
8/1/14 → 1/31/20
Project: Research project
-
Northwestern University Skin Disease Research Core Center
Paller, A. (PD/PI), Lavker, R. M. (Co-Investigator), Budunova, I. (Other), Getsios, S. (Other), Green, K. J. (Other), Guitart, J. (Other) & Yemelyanov, A. (Other)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
8/1/14 → 1/31/20
Project: Research project
-
-
Agmt 01/31/12: Dermatopathology Tissue Repository For Research
Guitart, J. (PD/PI)
1/31/12 → 1/31/15
Project: Research project
-
Prot# SHP-141-001: A Randomized, Double-blind, Placebo-Controlled, Dose-Escalating, Phase 1B Study to Assess the Safety, Pharmacodynamics and Pharmacokinetics of SHP-141, A Histone Deacetylase Inhibitor, Administered Topically up to 28 Days to Patients wi
Guitart, J. (PD/PI), Pedram, G. (Co-PD/PI) & West, D. P. (Co-PD/PI)
Therapeutics, Inc., Shape Pharmaceuticals, Inc.
10/4/11 → 10/4/14
Project: Research project
-
Northwestern University Skin Disease Research Core Center
Paller, A. (PD/PI), Lavker, R. M. (Co-Investigator), Budunova, I. (Other), Getsios, S. (Other), Green, K. J. (Other), Guitart, J. (Other) & Yemelyanov, A. (Other)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
8/1/09 → 6/30/14
Project: Research project
-
Prot# PG-041108: Utility of Vysis LSI Probes for RREB1/MYB/Cep6 and Vysis LSI Cyclin D1 Spectrum Green in Assessing Sentinel Lymph Node Status in Cases of Malignant Melanoma
Pedram, G. (PD/PI) & Guitart, J. (Co-PD/PI)
4/23/09 → 4/23/13
Project: Research project
-
Prot# 2007NMMF-202-US: An Open-Label Seven Month Study to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.04% Ointment Formulation in Patients with Stage I or IIA Mycosis Fungoides (MF) Who Have Completed an Initial 12 Month Treatment with Ni
Guitart, J. (PD/PI), Pedram, G. (Co-PD/PI) & West, D. P. (Co-PD/PI)
8/7/08 → 8/7/11
Project: Research project
-
Prot# 111441: Lapatinib - Histological Characterization and Differentiation of Rash from Other EGFR Inhibitors
Guitart, J. (Co-PD/PI), Pedram, G. (Co-PD/PI) & West, D. P. (Co-PD/PI)
1/11/08 → 1/11/11
Project: Research project
-
Prot# 20031/20061: Pilot Roll-in for Protocol 20061: Evaluation of Pigmented Skin Lesions with MelaFind® System
Martini, M. C. (PD/PI), Guitart, J. (Co-PD/PI), Pedram, G. (Co-PD/PI), Robinson, J. K. (Co-PD/PI) & West, D. P. (Co-PD/PI)
Electro-Optical Sciences, Inc.
8/15/07 → 8/15/10
Project: Research project
-
Prot# 20031/20061: Pilot Roll-in for Protocol 20061: Evaluation of Pigmented Skin Lesions with MelaFind® System
Martini, M. C. (PD/PI), Guitart, J. (Co-PD/PI), Pedram, G. (Co-PD/PI), Robinson, J. K. (Co-PD/PI) & West, D. P. (Co-PD/PI)
Electro-Optical Sciences, Inc.
8/15/07 → 8/15/10
Project: Research project
-
Early Access Program For Vysis LSI RREB1/LSI MYB/ CEP 6 Probes and Vysis LSI CCND1 SpectrumGreen TM Probe
Pedram, G. (PD/PI), Guitart, J. (Co-PD/PI) & West, D. P. (Co-PD/PI)
8/9/07 → 2/11/10
Project: Research project
-
Prot# 2005NMMF-201-US: A Phase II Pivotal Trial to Evaluate the Safety and Efficacy of Nitrogen Mustard (NM) 0.02% Ointment Formulations in Patients with Stage I or IIA Mycosis Fungoides (MF)
Guitart, J. (PD/PI) & Pedram, G. (Co-PD/PI)
6/13/07 → 2/1/12
Project: Research project
-
Prot# TG1042.06: Phase II Clinical Trial of Intra-Lesional Administration of TG1042 (Adenovirus-Interferon-gamma) in Patients with Relapsing Primary Cutaneous B-Cell Lymphomas
Guitart, J. (PD/PI), Kuzel, T. M. (Co-PD/PI) & Pedram, G. (Co-PD/PI)
12/8/06 → 1/20/10
Project: Research project
-
Prot# TG1042.06: Phase II Clinical Trial of Intra-Lesional Administration of TG1042 (Adenovirus-Interferon-gamma) in Patients with Relapsing Primary Cutaneous B-Cell Lymphomas
Guitart, J. (PD/PI), Kuzel, T. M. (Co-PD/PI) & Pedram, G. (Co-PD/PI)
12/8/06 → 1/20/10
Project: Research project